Clinical Trials Browser

Erythropoietin × Clear all

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT06135259 2024-02-01

Topical Erythropoietin Hydrogel in Management of Oral Lichen Planus

Phase 3 Unknown

18 enrolled

Lichen Planus, Oral

NCT05704894 2023-01-30

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Phase 3 Unknown

320 enrolled

Classical hematology

Anemia, Neoplasms

NCT00737893 2021-04-08

ERECT

Phase 2 Completed

56 enrolled 27 charts

Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT00254436 2018-10-25

A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients

Phase 3 Terminated

50 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Rectal Neoplasms

NCT00017004 2017-08-09

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

Phase 3 Completed

114 enrolled

Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

NCT01467115 2017-05-09

DREXNECK

Phase 2 Completed

1 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02767765 2017-04-04

A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

Phase 3 Completed

61 enrolled 11 charts

Classical hematology

Anemia

NCT03010579 2017-01-05

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Phase 4 Unknown

70 enrolled

Classical hematologyLymphoid

Anemia, Lymphoma

NCT01048034 2013-10-29

Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Phase 2 Completed

30 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT01099202 2012-08-27

Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy

Phase NA Completed

109 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01222195 2012-08-07

Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)

Phase 2 Terminated

1 enrolled 5 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes

NCT00348738 2007-11-02

Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome

Phase 3 Unknown

300 enrolled

Gynecologic

Uterine Cervical Neoplasms

Clinical Trials

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Topical Erythropoietin Hydrogel in Management of Oral Lichen Planus

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

ERECT

A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

DREXNECK

A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy

Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)

Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome